Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Regular Articles
Effect of Aminoguanidine on Lipopolysaccharide-Induced Changes in Rat Liver Transporters and Transcription Factors
Kimiko AokiMiki NakajimaYoshiyuki HoshiNaomi SasoSatoko KatoYuichi SugiyamaHitoshi Sato
Author information

2008 Volume 31 Issue 3 Pages 412-420


To determine the role of nitric oxide (NO) in rat liver transporter regulation, we investigated whether NO mediates lipopolysaccharide (LPS)-induced changes in transporters and their transcription factor expression using aminoguanidine (AG), an inhibitor of induced nitric oxide synthase (iNOS). We confirmed that LPS decreased mRNA levels for Ntcp, Oatp1, Oatp2, Oatp4, Oct1, Mrp2, Mdr1a and increased those for Mdr1b at 16 h after administration. AG attenuated these decreases for Ntcp, Oatp1 and Oatp4 (retinoid X receptor (RXR)α- and hepatocyte nuclear factor (HNF)4α-dependent genes) and increase for Mdr1b (nuclear factor (NF)-κB-dependent gene). Concomitantly, it suppressed LPS-induced NF-κB-dependent gene transcription, such as those for proinflammatory cytokines (cytokines; tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6) and iNOS, and also suppressed IL-1β release from Kupffer cells (KCs) at post-translational levels, but had little effect on the LPS-induced decreases in RXRα and HNF4α transcriptional activities. These findings indicate that hepatocytes were stimulated directly by LPS, which lead to the activation of NF-κB and reduction of RXRα and HNF4α transcriptional activities as early responses, and indirectly by cytokines and NO released from KCs via activation of NF-κB by LPS as delayed responses. We conclude that AG, which suppresses LPS-induced NF-κB activation in both hepatocytes and KCs and then the release of cytokines and NO from KCs, attenuates LPS-induced changes of Ntcp, Oatp1, Oatp4 and Mdr1b transcription in hepatocytes. The roles of cytokines and NO could not be distinguished, however. Further in vitro study is needed to clarify the role of NO in transporter regulation.

Content from these authors
© 2008 The Pharmaceutical Society of Japan
Previous article Next article